[Calculating the price of a new diagnostic or therapeutic option. Example of transurethral resection of bladder tumors using photodynamic diagnostics with hexaminolevulinic acid].
New diagnostic or therapeutic options (NDTOs) are remunerated separately in the German DRG system. The Institute for Remuneration in Hospitals decides which proposed NDTOs are accepted for separate remuneration for 1 year. With this acceptance, hospitals can enter negotiations with insurance companies for an individual price of the NDTO. Because there are no general recommendations for these negotiations, we present a scheme for how to calculate an NDTO, based on the example of the NDTO for transurethral resection of bladder tumors using photodynamic diagnostic with hexaminolevulinic acid.
Burger
M
M
Klinik für Urologie, Universität, Regensburg, Deutschland.
Petschl
S
S
Volkmer
B G
BG
D000622:Aminolevulinic Acid / Q000031:analogs & derivatives* / Q000191:economics; D001706:Biopsy / Q000191:economics*; D002017:Budgets / Q000458:organization & administration; D002295:Carcinoma, Transitional Cell / Q000175:diagnosis / Q000191:economics / Q000473:pathology / Q000601:surgery; D003362:Cost-Benefit Analysis / Q000331:legislation & jurisprudence; D003558:Cystoscopy / Q000191:economics*; D003953:Diagnosis-Related Groups / Q000191:economics* / Q000331:legislation & jurisprudence; D005858:Germany; D017721:Hospital Costs / Q000331:legislation & jurisprudence*; D006801:Humans; D053685:Laser Therapy / Q000191:economics*; D053844:Lasers, Solid-State / Q000627:therapeutic use*; D009313:National Health Programs / Q000191:economics* / Q000331:legislation & jurisprudence; D017008:Negotiating; D009367:Neoplasm Staging; D012051:Reimbursement Mechanisms / Q000191:economics* / Q000331:legislation & jurisprudence; D013675:Technology, High-Cost / Q000191:economics* / Q000331:legislation & jurisprudence; D013996:Time and Motion Studies; D001749:Urinary Bladder Neoplasms / Q000175:diagnosis / Q000191:economics* / Q000473:pathology / Q000601:surgery
D000622:Aminolevulinic Acid; C419924:5-aminolevulinic acid hexyl ester